We report the case of a 39-day-old infant with urinary tract infection combined with sepsis due to H. alvei infection. We also review the relevant literature for previously reported cases of extraintestinal invasive disease suspected to have been caused by H. alvei and occurring in pediatric patients.
Case Report
A 39-day-old infant presented to the emergency department at a local hospital for evaluation of a fever of approximately 48 hours' duration. The infant's initial physical examination was notable for a body temperature of 38.6°C and demonstrated irritability, although there appeared to be no obvious foci of infection. The contact history for the infant was traced back for the preceding several days during which time the patient had had a diaper change alongside another infant who was suffering from acute gastroenteritis at that time. Our patient's past history revealed that he was delivered by an uncomplicated vaginal delivery following a gestation period of 37 weeks, and that there appeared to have been no history of a prolonged rupture of the membrane. The infant's birth weight was 3070 g and there appeared to have been no prenatal, peripartum or postpartum complications reported for either the patient or his mother.
At the local hospital, the complete blood cell count revealed a white blood cell (WBC) count of 14. were positive included lysine decarboxylase, ornithine decarboxylase, and mannitol fermentation, whereas it was negative for fermentation of sorbitol, inositol, sucrose, and melibiose; these negative reactions differentiated H. alvei from Enterobacter aerogenes. For those cultures, antimicrobial susceptibility was performed by the disc-diffusion method, which revealed that H. alvei was resistant to ampicillin, cefazolin, piperacillin, chloramphenicol, and trimethoprim-sulfamethoxazole, and was susceptible to amoxicillin/clavulanate, cefaclor, cefotaxime, ceftriaxone, gentamicin, amikacin, ciprofloxacin, and meropenem. The patient was treated with a 14-day course of ceftriaxone at our institution and recovered completely. In addition, he also underwent a 2,3-dimercaptosuccinic acid (DMSA) renal scan and sonography of the kidneys. The DMSA renal scan demonstrated no evidence of pyelonephritis, while kidney sonography revealed bilateral mild hydronephrosis. Otherwise, all results from the patient's immunologic evaluation (including serum IgA, IgM, IgE, IgG, and IgD levels, lymphocyte profile, and C3, C4, and CH50) lay within the normal ranges. Furthermore, an HIV enzyme-linked immunosorbent assay antibody test was negative.
Discussion
H. alvei is a motile, facultatively anaerobic, Gramnegative bacillus, formerly referred to as Enterobacter hafnia. 1, 9 This organism typically constitutes a component of the normal human gastrointestinal flora and is typically found in environmental habitats such as surface water and certain foods. 1 These bacteria are rarely isolated from human specimens and are thought to be rarely pathogenic. 9 In 1991, Albert et al 10 H. alvei is a rare but significant etiologic agent of nosocomial and community-acquired infections. 9 It is primarily isolated from patients featuring underlying illness, apart from cases when it exists as an enteric pathogen. The pathogenesis of the invasive disease remains somewhat unclear, but the gastrointestinal tract has been implicated as a frequent source of the infection. 11 To our knowledge, the first reported case of purulent meningitis ascribable to H. alvei was in 1978, when it was assumed that the gastrointestinal tract was the port of entry for the bacteria and that meningitis arose secondarily to bacteremia. 7 In our case, the patient did feature a urinary tract infection and also bacteremia, and had a contact history with another infant who suffered from acute gastroenteritis at the time of contact. Such a medical scenario may suggest that H. alvei was retrograded to the urinary tract from where it then induced bacteremia. H. alvei would appear to be an infrequently reported pathogen among children, and its isolation from a neonate or a young infant is even more unusual. Subsequent to adequate antibiotic treatment, seven cases exhibited a full recovery. For the remaining one case, that of a 1-year-old female infant with H. alvei meningitis, the patient showed only a slight improvement subsequent to antibiotic treatment and, unfortunately, died of Pseudomonas aeruginosa sepsis. 7 For the seven cases that recovered, 10-14 days of antimicrobial therapy proved to be entirely effective for full patient recovery. H. alvei is usually resistant to ampicillin and first-generation cephalosporins because it features inducible and constitutive beta-lactamases, and under certain circumstances, can develop resistance to second-and third-generation cephalosporins. 1 For severe cases, treatment with imipenem or a third-generation cephalosporin in combination with an aminoglycoside is recommended by many clinicians. 9, 11 In general, piperacillin and gentamicin have been previously shown to be active against H. alvei. 9, 11, 13 According to our review in children, four cases (cases 5, 6, 7, 8; Table) underwent antibiotic-susceptibility testing prior to treatment. Three of them who underwent antibiotic-susceptibility testing for ampicillin were resistant (75% resistant). Two cases underwent antibiotic-susceptibility testing for piperacillin and revealed 100% resistance; four cases underwent susceptibility testing for gentamicin and the resistance rate was 25%. Apart from the abovementioned antibiotics, we noted that amikacin, imipenem and/or meropenem, and third-generation cephalosporins were the most effective antimicrobials for the four cases (zero resistance). In our case, ceftriaxone was used for 14 days, with a successful outcome. Cases of urinary tract infections due to H. alvei among adults have been reported previously. The largest case study report, which included 80 isolates of H. alvei recovered from 61 patients, reported that there were 12 such isolates detected from the urogenital tracts of seven patients. 9 Further, Ramos and Damaso 11 described three adult cases of hospital-acquired urinary tract infection, of which two patients had undergone previous urethral catheterization. This finding emphasizes the potential role of urethral catheters in the acquisition of nosocomial urinary tract infections. 11 Here, we have reported a rare case of young-infant sepsis combined with urinary tract infection caused by H. alvei. This is the first literature-reported case of urinary tract infection combined with sepsis caused by H. alvei in a young infant who featured no other underlying disease.
In conclusion, our case reminds diagnosing physicians that the possibility of an extraintestinal invasive infection such as bacteremia or urinary tract infection being caused by H. alvei should be taken into account in young infants who feature no apparent underlying disease. For cases of H. alvei infection featuring extraintestinal infection, effective treatment should be carefully selected based on the results of preliminary antimicrobialsusceptibility testing. Cases usually recover uneventfully after adequate antibiotic treatment for 10-14 days, except for the case of central nervous system infection. Although there would appear to be an absence of any large pediatric case studies relating to this topic reported in the literature, increased awareness and evaluation of the susceptibility pattern of the organism would allow appropriate antibiotic therapy in the future.
